Podcasts about associate physician

Send us a textIn honour of Endometriosis Awareness Month, tune in to this republished, intriguing episode with Dr. Sony Sierra, a renowned reproductive endocrinologist at TRIO Fertility in Toronto and a past president of the Canadian Fertility and Endocrinology Society. Dr. Sierra takes us deep into endometriosis, shedding light on this misunderstood condition.Dr. Sony Sierra unpacks the realities of endometriosis—its overlooked symptoms, diagnostic challenges, and misunderstood impact on fertility. She breaks down the three key ways it affects conception, the best treatment options, and what patients need to know at every stage of their journey. This episode is a must-listen for anyone seeking clarity, support, and empowerment in the fight for endometriosis awareness.More About our Guest Speaker:Dr. Sony Sierra, MD, FRCSC, REI (She/Her), serves as a distinguished Reproductive Endocrinology & Infertility Specialist (REI) and Deputy Medical Director and Partner at TRIO. With nearly two decades of experience, she specializes in reproductive health, recurrent pregnancy loss, and early Recurrent Pregnancy Loss (RPL) programs. As the Medical Director at EVOLVE Egg Freezing Clinic and an Associate Physician at Women's College Hospital, she contributes significantly to advancing reproductive medicine. Dr. Sierra's research interests include infertility, implantation failure, and PCOS, reflected in her publications and conference presentations. Passionate about patient care, she approaches her practice with compassion and dedication, guided by her belief in excellence and empathy. Dr. Sierra's commitment to ongoing education and involvement in esteemed societies ensures her patients receive the most up-to-date care and expertise. She finds immense fulfillment in helping individuals and couples achieve their dreams of starting a family, making her a valued asset in the field of fertility medicine.For more info about Dr. Sierra, you can check out the TRIO Fertility Website: https://triofertility.com/team-member/sony-sierra/ or their Instagram at @triofertility. Follow Dr. Sierra directly at @drsonysierra.If you or your organization would like to sponsor educational episodes just like this, please contact us at podcast@fertilitymatters.ca. Follow Fertility Matters Canada at @fertility_canada on Instagram and TikTok.

CANCER. It's a scary word. And when it comes to skin cancer, the fear is no different. May is Skin Cancer Awareness Month and this time is dedicated to educating people about skin cancers of all kinds. Did you know that globally, between 2 and 3 million cases of non-melanoma skin cancers are diagnosed each year? That's a staggering number, and it means that the chances of being diagnosed with skin cancer are higher than you might think. Be sure to listen to this week's podcast episode featuring Dr. Emily Ruiz, where we talk about non-melanoma skin cancers, tips for preventing skin cancer, and available treatment options. Key Takeaways: - Skin cancer is the most common type of cancer in the world, with basal cell carcinoma and squamous cell carcinoma being the most prevalent forms. - Sun protection is crucial in preventing skin cancer, including wearing protective clothing, using sunscreen, and avoiding midday sun exposure. - The Skin Cancer Champions online community provides support and resources for patients with skin cancer, including information on treatment options and connecting with others. - Other prevention methods include taking nicotinamide supplements and using chemo creams to remove damaged skin. - Early detection and treatment of skin cancer is important for better outcomes, and regular check-ups with a dermatologist are recommended for high-risk individuals. In This Episode: (6:50) Understanding the Different Types of Skin Cancer (9:50) How Do You Get Skin Cancer (11:48) Prevention Methods for Skin Cancer (20:00) Skin Cancer Champions ( 25:22) Nicotinamide   (30:30) Tips for People who have been Diagnosed with Skin Cancer Get Dr. Mina's free PDF on How to create Healthy Skin Habits here. Download the free eBook 'Skincare Myths Busted' here. Emily Ruiz, MD, MPH, is an Associate Physician at the Mohs and Dermatologic Surgery Center at Dana-Farber/Brigham and Women's Cancer Center, an Associate Professor in Dermatology at Harvard Medical School, Director of the High-Risk Skin Cancer Clinic at Dana Farber/Brigham and Women's Hospital, and Program Director of the Micrographic Surgery and Dermatologic Oncology Fellowship. Dr. Ruiz received her undergraduate degree from Duke University, medical degree from New York University School of Medicine, and Master of Public Health Degree from Harvard School of Public Health. She completed an internship in internal medicine at New York University School of Medicine, dermatology residency at Albert Einstein College of Medicine, and fellowship in Micrographic Surgery and Dermatologic Oncology at Brigham and Women's Hospital. Skin Cancer Champions is an online forum for those diagnosed with non-melanoma skin cancers. It's a place where you can find accurate information, connect with others who are on a similar journey, and feel supported every step of the way.  Follow Dr. Mina here:-  https://instagram.com/drminaskin https://www.facebook.com/drminaskin https://www.youtube.com/@drminaskin For more great skin care tips, subscribe to The Skin Real Podcast or visit www.theskinreal.com Baucom & Mina Derm Surgery, LLC Email - scheduling@atlantadermsurgery.com  Contact - (404) 844-0496 Instagram - https://www.instagram.com/baucomminamd/ Thanks for listening! The content of this podcast is for entertainment, educational, and informational purposes and does not constitute formal medical advice.

In honour of Endometriosis Awareness Month, we sit down with Dr. Sony Sierra, a renowned reproductive endocrinologist at TRIO Fertility in Toronto and a past president of the Canadian Fertility and Endocrinology Society. Dr. Sierra takes us deep into endometriosis, shedding light on this misunderstood condition.She begins by explaining what endometriosis is, delving into its symptoms, signs, and the challenges surrounding its diagnosis, including the various stages involved. Dr. Sierra discusses how commonly the symptoms and pain associated with menstruation are disregarded, emphasizing the importance of understanding and recognizing these signs.Dr. Sierra discusses the intricate relationship between endometriosis and fertility, outlining the three primary ways it impacts one's ability to conceive. She provides invaluable insights into what patients can expect if they suspect they have endometriosis, including the medical approaches to diagnosis and treatment.For those navigating their fertility journey, Dr. Sierra offers guidance on the best treatment options, whether they are actively trying to conceive or in the pre-planning phase. She also addresses how endometriosis affects everyday living. This episode equips listeners with the knowledge and tools to navigate endometriosis with confidence and empowerment. Tune in to gain a comprehensive understanding of endometriosis and join the movement toward greater awareness and transparency in reproductive health.More About our Guest SpeakerDr. Sony Sierra, MD, FRCSC, REI (She/Her), serves as a distinguished Reproductive Endocrinology & Infertility Specialist (REI) and Deputy Medical Director and Partner at TRIO. With nearly two decades of experience, she specializes in reproductive health, recurrent pregnancy loss, and early Recurrent Pregnancy Loss (RPL) programs. As the Medical Director at EVOLVE Egg Freezing Clinic and an Associate Physician at Women's College Hospital, she contributes significantly to advancing reproductive medicine. Dr. Sierra's research interests include infertility, implantation failure, and PCOS, reflected in her publications and conference presentations. Passionate about patient care, she approaches her practice with compassion and dedication, guided by her belief in excellence and empathy. Dr. Sierra's commitment to ongoing education and involvement in esteemed societies ensures her patients receive the most up-to-date care and expertise. She finds immense fulfillment in helping individuals and couples achieve their dreams of starting a family, making her a valued asset in the field of fertility medicine.For more info about Dr. Sierra, you can check out the TRIO Fertility Website: https://triofertility.com/team-member/sony-sierra/ or you can follow her on Instagram @drsonysierra. Afynia Laboratories, a Canadian biotechnology company, is pleased to announce the availability of EndomiR, the first validated diagnostic blood test for endometriosis. Afynia is currently offering EndomiR to Canadian fertility clinics for patients with unexplained infertility and/or symptoms suggestive of endometriosis. EndomiR shortens the diagnostic pathway by providing physicians with actionable data to inform safe and effective treatment options. EndomiR will be available to a wider au

In this episode, we speak with Dr. Suzanne Bertisch about sleeping pills. Dr. Bertisch is an Associate Physician and Clinical Director of Behavioral Sleep Medicine at Brigham and Women's Hospital, and an Assistant Professor of Medicine at Harvard Medical School. She has won several awards for her work in sleep medicine and has published on the use of pharmacologic and behavioral treatments of insomnia.  This topic is deeply personal to me, having relied on various sleep aids throughout my adult life—a decision I now view as my greatest health regret. I am profoundly concerned about the consequences of long-term use of these medications. Dr. Bertisch shares her expert perspective on the various classes of sleep medications (both over the counter and prescription), their effects on the brain, and offers practical advice for those considering or currently using these drugs, as well as strategies for safely reducing reliance on them. Much of our discussion covers insights I wish I had before taking my first sleep aid–I hope that this can help others avoid the nightmare I have endured. Host: Brent Franson, Founder & CEO, Most Days Guest: Dr. Suzanne Bertisch Music: Patrick Lee Producer: Patrick Godino

Physician Assistant remains one of the fastest growing professions in the US, and the expansion of their role in healthcare delivery seems to be growing just as quickly. One of the biggest changes in that regard, according to Jonathan Bowser of the University of Colorado Denver School of Medicine, is that states are opening up opportunities for PAs to practice with more autonomy to fill needs in the healthcare system. “That requires PA education programs to think about who are we putting out there, what environments they are going into, and how do we best prepare them for those environments,” says Bowser, who runs the school's Child Health Associate/Physician Assistant Program (CHAPA), one of the oldest PA training programs in the country. The need to adapt their program to these new realities and the desire to take advantage of advances in learning science led CHAPA to overhaul its curriculum in recent years. The result is a ‘spiral curriculum' - an iterative approach to learning that reinforces key concepts and knowledge as students progress through their years of training.  Join host Hillary Acer as she learns about the underpinnings of CHAPA's curricular approach, what the program is doing to prepare PAs to be leaders and the growing importance of residencies and fellowships to prepare PAs to work in clinical specialties. Mentioned in this episode: CHA/PA Program OverviewManaging Transitions by William BridgesMake It Stick by Peter Brown

In this interview, two of the authors of the paper Direct oral anticoagulants vs vitamin-K antagonists in thrombotic antiphospholipid syndrome: meta-analysis of randomized controlled trials, Dr Jean Connors and Dr Benhood Bikdeli, provide listeners with an overview of their systematic review and meta-analysis that evaluated the efficacy and safety of direct oral anticoagulants (DOACs) compared to vitamin K antagonists (VKAs) in patients with thrombotic antiphospholipid syndrome. The authors searched through three databases (PubMed, EMBASE, and Cochrane Central Register of Controlled Trials) and found four eligible randomized controlled trials with a total of 472 patients. Our podcast guests discuss the results of the study and the clinical implications.  About our guests:Dr Jean M Connors: Jean M. Connors, MD is a hematology attending at Brigham and Women's Hospital and Dana-Farber Cancer Institute; the Medical Director of the Anticoagulation Management Services, and the Hemostatic Antithrombotic Stewardship Program; and an Associate Professor of Medicine at Harvard Medical School. She received a medical degree from The Johns Hopkins University in Baltimore, completed her residency in internal medicine at Beth Israel Deaconess Medical Center in Boson, as well as fellowships in transfusion medicine and hematology & oncology from Brigham and Women's Hospital.Dr. Connors is an Associate Editor for the Journal of Thrombosis and Haemostasis and the Journal of the American College of Cardiology: Basic to Translational Science. She is a member of or holds a leadership role in many professional societies, including ASH and ISTH. She has participated in numerous clinical trials for patients with venous thrombosis in cancer, and anticoagulation questions in general.Dr Benhood Bikdeli:Behnood Bikdeli, MD, MS is a clinician-investigator, with training in cardiology and in vascular medicine who is particularly interested in thrombotic diseases. He is an Associate Physician in the Division of Cardiovascular Medicine at Brigham and Women's Hospital, an Instructor in Medicine at Harvard Medical School, and an investigator at Yale Center for Outcomes Research and Evaluation (CORE). His research has been funded by the NIH, the American Heart Association, Brigham and Women's Hospital and others. Dr Bikdeli has coauthored over 180 publications, which have been published in journals including Lancet, JAMA, JAMA Internal Medicine, Circulation, Journal of the American College of Cardiology, the British Medical Journal, and others. Dr. Bikdeli was the lead author of two international consensus documents related to thrombosis in COVID-19, is the joint principal investigator of the INSPIRATION/ INSPIRATION-S randomized controlled trial, and is an Associate Editor for Thrombosis Research. Ref:Khairani, C. D., Bejjani, A., Piazza, G., Jimenez, D., Monreal, M., Chatterjee, S., ... & Bikdeli, B. (2022). Direct oral anticoagulants vs vitamin-K antagonists in thrombotic antiphospholipid syndrome: meta-analysis of randomized controlled trials. Journal of the American College of Cardiology.Follow us on Twitter:@thrombosiscan@connors_mdSupport the showhttps://thrombosiscanada.caTake a look at our healthcare professional and patient resources, videos and publications on thrombosis from the expert members of Thrombosis Canada

Synopsis: Keith Flaherty is the Director of Clinical Research at Mass General Cancer Center and a Professor of Medicine at Harvard Medical School. Dr. Flaherty is a medical oncologist and has worked in the field for 22 years, during which he has founded seven biotech companies. He joins Rahul for an in-depth conversation about his work in oncology. They cover a wide range of topics including his early decision in school to switch from neuroscience to oncology, his entrepreneurial journey and what he's learned along the way, his perspective on the immuno-oncology landscape and opportunities that lie ahead in this field, what he values in a board and how you can be most effective as a board member, and much more. Biography: Dr. Keith Flaherty is the Director of Clinical Research at Mass General Cancer Center, a Professor of Medicine at Harvard Medical School, and an Associate Physician of Medicine, Hematology/Oncology at Massachusetts General Hospital. Dr. Flaherty is also the Deputy Chair for Biomarker Sciences and the Chair of the Developmental Therapeutics Committee in the Eastern Cooperative Oncology Group. Dr. Flaherty has served as Principal Investigator for numerous first-in-human clinical trials with novel, targeted therapies, including the first in-human trials of the first prospectively developed selective BRAF inhibitors for metastatic melanoma and has published more than 300 peer-reviewed papers. He currently serves on the board of directors of Scorpion Therapeutics (founder), Strata Oncology (founder), Kinnate Biopharma, and Clovis Oncology. Dr. Flaherty has a Bachelor of Science from Yale University and medical degree from Johns Hopkins University. Dr. Flaherty trained in internal medicine at Brigham and Women's Hospital and completed a medical oncology fellowship at the University of Pennsylvania.

While many physicians are called to the profession from a young age or commit to it early in life because of onerous pre-requisites and medical school admission requirements, others find their way to the bedside through more meandering routes. When the leap into medicine spans such a great distance, when the change of direction from a person's past pursuits into the profession is so abrupt, I automatically become curious. What happened in this person's life, or in their mind, to send them from one domain, one particular way of thinking about the world or going about their days, into the very different and idiosyncratic world of medical training and practice?  As a doctoral candidate writing a thesis on the ethics of war, Will Feldman felt a need to take his ethical reasoning and moral questions outside of the theoretical realm and into the real world. That's what brought him to a neurology ward as an observer and, a decade later, to his work as a critical care physician, clinical ethicist, and health services researcher.  William B. Feldman completed his doctorate in Political Theory from Oxford University before entering medical school at the University of California San Francisco. He subsequently completed his internship and residency in Internal Medicine at Brigham and Women's Hospital in Boston, along with a Master's of Public Health at Harvard University and a Fellowship in Pulmonary and Critical Care at Brigham and Women's. He is now Associate Physician in theDivision of Pulmonary and Critical Care Medicine at Brigham and Women's Hospital and Faculty in the Program On Regulation, Therapeutics And Law (PORTAL) and Co-Chair of that hospital's Ethics Committee and Associate Director of its Ethics Service. Will's credentials and background may seem quite distant from the daily reality of critical care medicine or pulmonology clinic, and yet our conversation revealed how he has woven together the many strands of his academic and professional development into a coherent and meaningful whole. Speaking to Will also illustrates something I've always felt to be true: that diverse approaches, backgrounds and intellectual traditions only serve to deepen medicine's impact and relevance. ***Links:Will's profile and twitterInformed consent paper Crisis standards of care paperOTC inhaler paper and tweet threadInhaler patents paper and tweet thread CBC article on effort to regulate Canadian drug prices***Recorded May 20, 2022Music: Mr Smith  Art: Jeff Landman

Ch.1: A majority of Canadians say they're still in support of another lockdown to stop the spread of the Omicron COVID-19 variant, a new poll has found. Guest: Darrell Bricker, CEO of IPSOS Public Affairs. Ch.2: There is a lot of concern right now about the potential impact Omicron is going to have on our healthcare system. Guest:  Dr. Kendall Ho, Professor, Department of Emergency Medicine, UBC and Associate Physician, Department of Emergency Medicine, Vancouver General Hospital. Ch.3: It appears B.C. is considering new restrictions as COVID-19 cases rise and concerns about the Omicron variant remain high. Guest: Sarah Otto, Professor and Mathematical Biologist at The University of British Columbia. Ch.4: The Coquihalla Highway is set to reopen on Dec. 20, well ahead of the previously announced timeline. Guest: Rob Fleming, Provincial Transportation Minister. See omnystudio.com/listener for privacy information.

Dr. Alan Brown sits down with Zareen Farukhi, MD, MPH,  Associate Physician at Brigham and Women's Hospital and Instructor at Harvard; and Rachel M. Bond, MD, FACC, System Director for Women's Health at Dignity Health and Assistant Professor of Medicine at Creighton University. Today, the discuss important topics in Women's Cardiovascular Health.

Fred J. Schiffman, MD, is a Hematologist/Oncologist and the Associate Physician-in-Chief at The Miriam Hospital, the Medical Director of the Lifespan Cancer Institute, the Sigal Family Professor of Humanistic Medicine and the Vice-Chairman of the Department of Medicine at the Warren Alpert School of Medicine at Brown University. Dr. Schiffman is a graduate of NYU Medical School. He completed his residency in Internal Medicine and fellowship in Hematology/Oncology from Yale New Haven Hospital. Dr. Schiffman has published extensively in hematologic malignancies and on a variety of subjects regarding the education of students and house staff. He has received numerous teaching awards, including the Charles C. J. Carpenter Award for excellence in the specialty of Internal Medicine, and the Human Dignity Award given by Home & Hospice Care of Rhode Island. “At the end of the day, when you're off the clock, go to the patient's room. Ask about their day; answer their worries; reassure them of your support; give them your undivided attention; clear your mind of all distracting thoughts, and just be there for the patient.” Today we listen to Dr. Fred Schiffman share his journey, reflecting on our broader role as physicians in treating illness, not just disease. “Cure sometimes, relieve often, and comfort always” is one of Dr. Schiffman's many mantras, encouraging us to allow our humanistic side to shine through as we care for our patients. Pearls of Wisdom: 1. The secret to dealing with learners that have difficulty is to capitalize on their strengths, and to never criticize the person, only the incorrect method or behavior. 2. Be present with the patient. Give them your undivided attention. When you are off the clock at the end of the day, spend five minutes to ask about their day. 3. As our career progresses, we often forget the compassion and love that inspired us to enter the field of medicine. To reconnect with the warmth of those ideals, simply take five minutes to reflect on what you would want if you were on the other side of the stethoscope.

Dr. Desai is an Associate Physician in the Division of Rheumatology, Inflammation, and Immunity at Brigham and Women's Hospital and an Assistant Professor of Medicine at Harvard Medical School. In addition to her patient care and educational duties, she serves as Associate Chief Quality Officer at Brigham and Women's Hospital.She has served on national advisory committees with the National Quality Forum and serves as Deputy Editor for the International Journal for Quality In Healthcare – an Oxford University Press peer-reviewed publication.Dr. Desai's accolades include the Donabedian award for Quality and Safety in 2019 from the American Public Health Association, for her work in reducing diagnostic error through the ambulatory safety net programs. This work has been presented at several national conferences including the National Patient Safety Foundation, the Society for Diagnosis in Medicine and Vizient.Dr. Desai is also and served as a Program Director (2015-2017) for an innovative global education, blended learning course titled Safety, Quality, Informatics, and Leadership at HMS. She is a native of Massachusetts and attended both college and medical school at Brown University in Rhode Island. She completed her internal medicine residency and Chief residency at Beth Israel Deaconess Medical Center in Boston, her rheumatology fellowship at BWH, and her Master's in Public Health at the Harvard School of Public Health.Enjoy this episode? Leave feedback so the episodes can continually improve and add value.https://www.surveymonkey.com/r/JNH2Q62

In depth conversation with orthopaedic surgeon Dr. John Grant, Head Team Physician for Eastern Michigan University Athletics and the USA Hockey National Team Development Program. Dr. Grant talks about his experience in managing common hockey injuries and the players.Dr. Grant obtained his PhD in Kinesiology with a specialization in Bone & Joint Health from the University of Calgary Sport Medicine Centre under the mentorship of Dr. Nicholas Mohtadi and Dr. Ron Zernicke. He then attended the University of Calgary Medical School and completed residency training in Orthopaedic Surgery at the University of Calgary in 2010.Dr. Grant completed sub-specialty training in Orthopaedic Sports Medicine and Shoulder Surgery at the University of Michigan. This fellowship covered a wide range of sports medicine and shoulder surgery from cartilage and ligament injuries in children & adolescents, through adult knee ligament reconstruction & shoulder instability management, to rotator cuff tears and shoulder replacement in older adults. Care of the elite athlete involved the University of Michigan Wolverines and Eastern Michigan University athletic teams. Particular time was spent with the NCAA Division I football programs at both universities and Michigan’s women's gymnastics team.Dr. Grant specializes in all disorders of the shoulder, including rotator cuff repairs, shoulder replacements, shoulder instability and other sports related injuries.  His practice also includes ligamentous injuries of the knee (ACL, LCL, PCL and MCL), meniscal injuries, knee realignment procedures and other sports related injuries. He is a former Associate Physician with the Saint John Seadogs of the Quebec Major Junior Hockey League and is currently the Head Team Orthopaedic Surgeon for Eastern Michigan University Athletics and a Consultant to the University of Michigan Athletics Department.Dr. Grant’s research interests include clinical decision making in sports injuries of the knee and shoulder, pre- and post-operative rehabilitation of the knee and shoulder, prevention of sports-related injuries.This Episode is presented by our proud sponsor JRF Ortho, The Leader in Allograft Joint Restoration - JRFORTHO.org

Dr. Ingrid Katz is an Associate Director at the Harvard Global Health Institute, Associate Physician in the Department of Medicine at Brigham and Women's Hospital, Assistant Professor in Medicine at Harvard Medical School, and a research scientist at the Center for Global Health at Massachusetts General Hospital. Ingrid's research focuses on the social determinants of health-seeking behavior among people living with HIV in South Africa. Ingrid talks with Valerie and Carly about biking across the country after college to raise awareness about HIV, her interest in the “complexity of the human condition”, the value of interdisciplinary teams, her many work hats (doctor, scientist, teacher), and being part of the first openly gay couple to match at a Harvard-affiliated hospital. Read more about Dr. Katz's work here: https://globalhealth.harvard.edu/team/ingrid-katz/Follow her on Twitter: @IngridKatzMDAccess recordings from Dr. Katz's class (Confronting COVID-19: Science, History, Policy) here: https://globalhealth.harvard.edu/domains/pandemics/courses/Watch Dr. Katz chat with the Time for Kids reporters about COVID-19 here: https://www.timeforkids.com/g56/ask-the-expert-katz/

The Berkman Klein Center for Internet & Society at Harvard University, Harvard Medical School’s Program in Global Public Policy and Social Change, the National Governors Association, and Partners In Health’s U.S. Public Health Accompaniment Unit hold a session exploring how US state and local public health leaders can implement retrospective contact tracing to identify Covid-19 clusters and mitigate their spread. Currently, almost every US state relies on prospective contact tracing: when an infected person is identified, contact tracers try to identify and notify the infected person’s contacts since being infected. However, there’s an additional, effective method that states can add to their toolkit: retrospective tracing. Once tracers identify an infected person, they can look backwards to find when and where the person was infected and identify who else might have been infected simultaneously as part of a ‘cluster’. Experts are increasingly aware of the outsized effects of superspreader incidents in the transmission of COVID-19 — these are occasions where one or a few persons infect a disproportionate number of other individuals due to a combination of environmental factors, timing, and the activities people are engaged in. As pioneered by Japanese scientists and officials, retrospective tracing identifies those events and allows tracers to discover more cases, more efficiently. Participants Dr. Hitoshi Oshitani, a member of Japan’s Subcommittee on Novel Coronavirus Disease Control whose pioneering work helped develop the retrospective tracing methodology, presents on the retrospective tracing methodology, how it was developed, and how it has been implemented in Japan. Dr. KJ Seung, chief of strategy and policy for Partners in Health’s MA COVID-19 Response, Associate Physician at the Division of Global Health Equity at Brigham and Women's Hospital, and Assistant Professor at the Department of Global Health and Social Medicine at Harvard Medical School presents on how the state of Massachusetts is implementing retrospective tracing methodologies. Professor Zeynep Tufekci, a techno-sociologist at the University of North Carolina who writes publicly on pandemic response for outlets including The Atlantic and is a member of the Berkman Klein Center’s Digital Pandemic Response Working Group, joins Drs. Seung, Oshitani, and Bourdeaux for a question and answer panel focused on implementation of this methodology. Dr. Margaret Bourdeaux, Research Director of the Program in Global Public Policy and Social Change and co-lead of the Berkman Klein Center’s Digital Pandemic Response Policy Practice, introduces and moderates the session.

Help me welcome, Dr. Carolyn Ho. Dr. Ho is the Medical Director of the Cardiovascular Genetics Center at Brigham and Women’s Hospital in Boston, MA. She is an Associate Physician at Brigham and Women’s Hospital and an Associate Professor of Medicine at Harvard Medical School. Dr. Ho completed her undergraduate education at Yale University, and went on to complete Medical School at Harvard Medical School. She trained in Internal Medicine at Brigham and Women’s Hospital, completing her fellowship in Cardiology/Cardiovascular Disease at Brigham and Women’s Hospital. Her research and clinical interest is in the diagnosis and management of hypertrophic cardiomyopathy (HCM).

Streamed live from the 2019 Prehabilitation World Congress and Annual London Peri-Operative Medicine Congress. Presented by Monty Mythen, Desiree Chappell and Korey Sprigman with their guest Teodor Stefanov, Associate Physician, Anesthesiology Institute at Cleaveland Clinic, Abu Dhabi.

Dr. Bennet Omalu, Clinical Professor and Associate Physician of Pathology and Laboratory Medicine at UC Davis Health and President and Medical Director of Bennet Omalu Pathology, gives the keynote address at the UC Davis Graduate Studies commencement ceremony, June 13th, 2019 at the ARC Pavilion.

This week we Flashback to one of our more popular shows with Christine Oliver, MD. Dr. Oliver joined us to discuss Odors and Chemical Sensitivities about 2 years ago. This was prior to our first YouTube videos so we are going to add some graphics and photos this week. Dr. Oliver is President of Occupational Health Initiatives, Inc. in Brookline, MA. She is an Associate Physician in the Department of Medicine (Pulmonary and Critical Care Division) at the Massachusetts General Hospital (MGH) and Associate Clinical Professor of Medicine at Harvard Medical School in Boston. Board certified in occupational medicine and in internal medicine. Dr. Oliver’s primary specialty is Occupational and Environmental Medicine, with an emphasis on occupational and environmental lung disease. At the MGH she evaluates and cares for patients with occupational and environmental illness and disease, including occupational asthma, interstitial lung disease, building-related health problems, and chemical sensitivities. Dr. Oliver has done research and published in the area of occupational lung disease and she has testified before the United States Congress with regard to work-related health issues and risks. For the past three decades an important focus of Dr. Oliver’s consulting work has been indoor air quality and related health effects. She has lectured and published on this subject and she has been actively involved in indoor air quality assessments in a variety of settings. These include health care facilities, courthouses and other government buildings, schools, and commercial office buildings. Together with industrial hygienists, engineers, and human systems specialists she has worked to identify, characterize, and resolve air quality problems and their related health effects. In 2009 she was a participant and presenter in the ASTM Johnson Conference on the standardization of mold response procedures. An important component of Dr. Oliver’s clinical work has been in the area of fragrances and their related health effects, including causation and/or exacerbation of chemical sensitivities. She has lectured on these topics, counseled patients and their families with regard to steps that can be taken to identify and remove fragranced products from their environment, and advocated for a fragrance-free policy in the clinic in which she works.

This week we Flashback to one of our more popular shows with Christine Oliver, MD. Dr. Oliver joined us to discuss Odors and Chemical Sensitivities about 2 years ago. This was prior to our first YouTube videos so we are going to add some graphics and photos this week. Dr. Oliver is President of Occupational Health Initiatives, Inc. in Brookline, MA. She is an Associate Physician in the Department of Medicine (Pulmonary and Critical Care Division) at the Massachusetts General Hospital (MGH) and Associate Clinical Professor of Medicine at Harvard Medical School in Boston. Board certified in occupational medicine and in internal medicine. Dr. Oliver's primary specialty is Occupational and Environmental Medicine, with an emphasis on occupational and environmental lung disease. At the MGH she evaluates and cares for patients with occupational and environmental illness and disease, including occupational asthma, interstitial lung disease, building-related health problems, and chemical sensitivities. Dr. Oliver has done research and published in the area of occupational lung disease and she has testified before the United States Congress with regard to work-related health issues and risks.    For the past three decades an important focus of Dr. Oliver's consulting work has been indoor air quality and related health effects. She has lectured and published on this subject and she has been actively involved in indoor air quality assessments in a variety of settings. These include health care facilities, courthouses and other government buildings, schools, and commercial office buildings. Together with industrial hygienists, engineers, and human systems specialists she has worked to identify, characterize, and resolve air quality problems and their related health effects. In 2009 she was a participant and presenter in the ASTM Johnson Conference on the standardization of mold response procedures. An important component of Dr. Oliver's clinical work has been in the area of fragrances and their related health effects, including causation and/or exacerbation of chemical sensitivities. She has lectured on these topics, counseled patients and their families with regard to steps that can be taken to identify and remove fragranced products from their environment, and advocated for a fragrance-free policy in the clinic in which she works.

Date: March 23, 2017 Featuring: Jose Figueroa, MD, MPH, Instructor of Medicine, Harvard Medical School; Associate Physician, Brigham and Women’s Hospital David Labby, MD, PhD, Health Strategy Adviser, Health Share of Oregon Marian Bihrle Johnson, MPH, Director of Innovation, IHI There’s a lot of attention being paid to developing new models to care for and support patients with multiple, complex health problems. And, for good reason. It’s long been known that individuals with chronic, intertwined health and social issues make frequent use of expensive emergency departments or stay away from health care altogether until things get really bad. The motivation of providers to change this situation is strong. So is their desire to find out how others are addressing the problem, to avoid starting from scratch. That’s where a newly available online resource comes in called The Playbook: Better Care for People with Complex Needs. Spearheaded by five foundations and developed by IHI, this episode of WIHI orients you to the Playbook’s rich offerings. For more information and context on the podcast, we encourage you to download the resources, chat, and slides offered below.

This week we welcome Christine Oliver, MD to the show. Dr. Oliver is President of Occupational Health Initiatives, Inc. in Brookline, MA. She is an Associate Physician in the Department of Medicine (Pulmonary and Critical Care Division) at the Massachusetts General Hospital (MGH) and Associate Clinical Professor of Medicine at Harvard Medical School in Boston. Board certified in occupational medicine and in internal medicine, Dr. Oliver's primary specialty is Occupational and Environmental Medicine, with an emphasis on occupational and environmental lung disease. At the MGH she evaluates and cares for patients with occupational and environmental illness and disease, including occupational asthma, interstitial lung disease, building-related health problems, and chemical sensitivities. Dr. Oliver has done research and published in the area of occupational lung disease and she has testified before the United States Congress with regard to work-related health issues and risks. For the past three decades an important focus of Dr. Oliver's consulting work has been indoor air quality and related health effects. She has lectured and published on this subject and she has been actively involved in indoor air quality assessments in a variety of settings. These include health care facilities, courthouses and other government buildings, schools, and commercial office buildings. Together with industrial hygienists, engineers, and human systems specialists she has worked to identify, characterize, and resolve air quality problems and their related health effects. In 2009 she was a participant and presenter in the ASTM Johnson Conference on the standardization of mold response procedures. An important component of Dr. Oliver's clinical work has been in the area of fragrances and their related health effects, including causation and/or exacerbation of chemical sensitivities. She has lectured on these topics, counseled patients and their families with regard to steps that can be taken to identify and remove fragranced products from their environment, and advocated for a fragrance-free policy in the clinic in which she works

This week we welcome Christine Oliver, MD to the show. Dr. Oliver is President of Occupational Health Initiatives, Inc. in Brookline, MA. She is an Associate Physician in the Department of Medicine (Pulmonary and Critical Care Division) at the Massachusetts General Hospital (MGH) and Associate Clinical Professor of Medicine at Harvard Medical School in Boston. Board certified in occupational medicine and in internal medicine, Dr. Oliver's primary specialty is Occupational and Environmental Medicine, with an emphasis on occupational and environmental lung disease. At the MGH she evaluates and cares for patients with occupational and environmental illness and disease, including occupational asthma, interstitial lung disease, building-related health problems, and chemical sensitivities. Dr. Oliver has done research and published in the area of occupational lung disease and she has testified before the United States Congress with regard to work-related health issues and risks. For the past three decades an important focus of Dr. Oliver's consulting work has been indoor air quality and related health effects. She has lectured and published on this subject and she has been actively involved in indoor air quality assessments in a variety of settings. These include health care facilities, courthouses and other government buildings, schools, and commercial office buildings. Together with industrial hygienists, engineers, and human systems specialists she has worked to identify, characterize, and resolve air quality problems and their related health effects. In 2009 she was a participant and presenter in the ASTM Johnson Conference on the standardization of mold response procedures. An important component of Dr. Oliver's clinical work has been in the area of fragrances and their related health effects, including causation and/or exacerbation of chemical sensitivities. She has lectured on these topics, counseled patients and their families with regard to steps that can be taken to identify and remove fragranced products from their environment, and advocated for a fragrance-free policy in the clinic in which she works

Dr. Katz is Associate Physician at Brigham and Women's Hospital and Associate Professor of Medicine at Harvard Medical School. This is a recording of the special session from the PRIME national conference in Louisville, KY on May 10th, 2012.